| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
STARLING REVIEW |  |
Laboratory of Molecular Endocrinology and Oncology, Laval University Hospital Research Center (CRCHUL) and Laval University, Québec City, Québec G1 V 4 G2, Canada
(Requests for offprints should be addressed to F Labrie; Email: fernand.labrie{at}crchul.ulaval.ca)
Dehydroepiandrosterone (DHEA) is not a hormone but it is a very important prohormone secreted in large amounts by the adrenals in humans and other primates, but not in lower species. It is secreted in larger quantities than cortisol and is present in the blood at concentrations only second to cholesterol. All the enzymes required to transform DHEA into androgens and/or estrogens are expressed in a cell-specific manner in a large series of peripheral target tissues, thus permitting all androgen-sensitive and estrogen-sensitive tissues to make locally and control the intracellular levels of sex steroids according to local needs. This new field of endocrinology has been called intracrinology. In women, after menopause, all estrogens and almost all androgens are made locally in peripheral tissues from DHEA which indirectly exerts effects, among others, on bone formation, adiposity, muscle, insulin and glucose metabolism, skin, libido and well-being. In men, where the secretion of androgens by the testicles continues for life, the contribution of DHEA to androgens has been best evaluated in the prostate where about 50% of androgens are made locally from DHEA. Such knowledge has led to the development of combined androgen blockade (CAB), a treatment which adds a pure anti-androgen to medical (GnRH agonist) or surgical castration in order to block the access of the androgens made locally to the androgen receptor. In fact, CAB has been the first treatment demonstrated to prolong life in advanced prostate cancer while recent data indicate that it can permit long-term control and probably cure in at least 90% of cases of localized prostate cancer. The new field of intracrinology or local formation of sex steroids from DHEA in target tissues has permitted major advances in the treatment of the two most frequent cancers, namely breast and prostate cancer, while its potential use as a physiological HRT could well provide a physiological balance of androgens and estrogens, thus offering exciting possibilities for women’s health at menopause.
This article has been cited by other articles:
|
|
 |
|
  A. Mizokami, E. Koh, K. Izumi, K. Narimoto, M. Takeda, S. Honma, J. Dai, E. T Keller, and M. Namiki Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone Endocr. Relat. Cancer, December 1, 2009; 16(4): 1139 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-G. Hui, J.-i. Akahira, T. Suzuki, M. Nio, Y. Nakamura, H. Suzuki, W. E Rainey, and H. Sasano Development of the human adrenal zona reticularis: morphometric and immunohistochemical studies from birth to adolescence J. Endocrinol., November 1, 2009; 203(2): 241 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Forsblad-d'Elia, H. Carlsten, F. Labrie, Y. T. Konttinen, and C. Ohlsson Low Serum Levels of Sex Steroids Are Associated with Disease Characteristics in Primary Sjogren's Syndrome; Supplementation with Dehydroepiandrosterone Restores the Concentrations J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2044 - 2051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakamura, P. J. Hornsby, P. Casson, R. Morimoto, F. Satoh, Y. Xing, M. R. Kennedy, H. Sasano, and W. E. Rainey Type 5 17{beta}-Hydroxysteroid Dehydrogenase (AKR1C3) Contributes to Testosterone Production in the Adrenal Reticularis J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2192 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Schaumberg, R. Dana, J. E. Buring, and D. A. Sullivan Prevalence of Dry Eye Disease Among US Men: Estimates From the Physicians' Health Studies Arch Ophthalmol, June 1, 2009; 127(6): 763 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Binder, S. Weber, M. Ehrismann, N. Zaiser, C. Meisner, M. B. Ranke, L. Maier, S. A. Wudy, M. F. Hartmann, U. Heinrich, et al. Effects of Dehydroepiandrosterone Therapy on Pubic Hair Growth and Psychological Well-Being in Adolescent Girls and Young Women with Central Adrenal Insufficiency: A Double-Blind, Randomized, Placebo-Controlled Phase III Trial J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1182 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Metwally, S. Amer, T.C. Li, and W.L. Ledger An RCT of metformin versus orlistat for the management of obese anovulatory women Hum. Reprod., April 1, 2009; 24(4): 966 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. van Gils, P. H.M. Peeters, M. C.J. Schoenmakers, R. M. Nijmeijer, N. C. Onland-Moret, Y. T. van der Schouw, and E. M. Monninkhof Physical Activity and Endogenous Sex Hormone Levels in Postmenopausal Women: a Cross-Sectional Study in the Prospect-EPIC Cohort Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 377 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Wang, W. Wang, K. Wahala, H. Adlercreutz, E. Ikonen, and M. J. Tikkanen Role of lysosomal acid lipase in the intracellular metabolism of LDL-transported dehydroepiandrosterone-fatty acyl esters Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1455 - E1461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. M. Newman, D. S. Pradhan, and K. K. Soma Dehydroepiandrosterone and Corticosterone Are Regulated by Season and Acute Stress in a Wild Songbird: Jugular Versus Brachial Plasma Endocrinology, May 1, 2008; 149(5): 2537 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sato, M. Iemitsu, K. Aizawa, and R. Ajisaka Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E961 - E968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Komesaroff Unravelling the Enigma of Dehydroepiandrosterone: Moving Forward Step by Step Endocrinology, March 1, 2008; 149(3): 886 - 888. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Aizawa, M. Iemitsu, T. Otsuki, S. Maeda, T. Miyauchi, and N. Mesaki Sex differences in steroidogenesis in skeletal muscle following a single bout of exercise in rats J Appl Physiol, January 1, 2008; 104(1): 67 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Roberge, A. C. Carpentier, M.-F. Langlois, J.-P. Baillargeon, J.-L. Ardilouze, P. Maheux, and N. Gallo-Payet Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1465 - E1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Marinelli, E. Trevisi, L. Da Dalt, M. Merlo, G. Bertoni, and G. Gabai Dehydroepiandrosterone secretion in dairy cattle is episodic and unaffected by ACTH stimulation J. Endocrinol., September 1, 2007; 194(3): 627 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kohalmy, V. Tamasi, L. Kobori, E. Sarvary, J.-M. Pascussi, P. Porrogi, D. Rozman, R. A. Prough, U. A. Meyer, and K. Monostory Dehydroepiandrosterone Induces Human CYP2B6 through the Constitutive Androstane Receptor Drug Metab. Dispos., September 1, 2007; 35(9): 1495 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Takeuchi, N. Mukai, T. Tateishi, and S. Miyakawa Production of sex steroid hormones from DHEA in articular chondrocyte of rats Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E410 - E415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.L. Hendriks, J.C.F. Ket, P.G.A. Hompes, R. Homburg, and C.B. Lambalk Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome Hum. Reprod. Update, May 1, 2007; 13(3): 249 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Golden, A. S. Dobs, D. Vaidya, M. Szklo, S. Gapstur, P. Kopp, K. Liu, and P. Ouyang Endogenous Sex Hormones and Glucose Tolerance Status in Postmenopausal Women J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1289 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Aizawa, M. Iemitsu, S. Maeda, S. Jesmin, T. Otsuki, C. N. Mowa, T. Miyauchi, and N. Mesaki Expression of steroidogenic enzymes and synthesis of sex steroid hormones from DHEA in skeletal muscle of rats Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E577 - E584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Wierman, R. Basson, S. R. Davis, S. Khosla, K. K. Miller, W. Rosner, and N. Santoro Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3697 - 3710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Labrie Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA. Endocr. Relat. Cancer, June 1, 2006; 13(2): 335 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Basson Sexual Desire and Arousal Disorders in Women N. Engl. J. Med., April 6, 2006; 354(14): 1497 - 1506. [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
